{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/03/3305970/0/en/Spyre-Therapeutics-Announces-Completion-of-Enrollment-in-SKYWAY-Basket-Trial-Evaluating-SPY072-anti-TL1A-in-RA-PsA-and-axSpA.html", "message": "News view counter 777151 successfully enlarged"}